(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202403 | 202303 | % Var | 202403 | 202303 | % Var | 202403 | 202303 | % Var | |
| Sales | 44.39 | 28.43 | 56.14 | 185.08 | 131.85 | 40.37 | 185.08 | 131.85 | 40.37 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDT | 0.71 | -1.11 | -163.96 | 5.89 | 4.63 | 27.21 | 5.89 | 4.63 | 27.21 |
| Interest | 0.50 | 0.47 | 6.38 | 0.56 | 0.58 | -3.45 | 0.56 | 0.58 | -3.45 |
| PBDT | 0.21 | -1.58 | -113.29 | 5.33 | 4.05 | 31.60 | 5.33 | 4.05 | 31.60 |
| Depreciation | 0.23 | 0.19 | 21.05 | 0.81 | 0.77 | 5.19 | 0.81 | 0.77 | 5.19 |
| PBT | -0.02 | -1.77 | -98.87 | 4.52 | 3.28 | 37.80 | 4.52 | 3.28 | 37.80 |
| TAX | 1.74 | 0.47 | 270.21 | 1.74 | 0.47 | 270.21 | 1.74 | 0.47 | 270.21 |
| Deferred Tax | 0.06 | 0.47 | -87.23 | 0.06 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 |
| PAT | -1.76 | -2.24 | -21.43 | 2.78 | 2.81 | -1.07 | 2.78 | 2.81 | -1.07 |
| Equity | 44.81 | 44.81 | 0.00 | 44.81 | 44.81 | 0.00 | 44.81 | 44.81 | 0.00 |
| PBIDTM(%) | 1.60 | -3.90 | -140.97 | 3.18 | 3.51 | -9.37 | 3.18 | 3.51 | -9.37 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: